Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 1
2001 2
2003 1
2004 1
2005 3
2006 1
2007 4
2008 3
2009 2
2010 1
2011 1
2012 1
2013 2
2014 3
2015 5
2016 10
2017 3
2018 2
2019 5
2020 7
2021 7
2022 13
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Development of the clinical assessment scale in autoimmune encephalitis.
Lim JA, Lee ST, Moon J, Jun JS, Kim TJ, Shin YW, Abdullah S, Byun JI, Sunwoo JS, Kim KT, Yang TW, Lee WJ, Moon HJ, Kim DW, Lim BC, Cho YW, Yang TH, Kim HJ, Kim YS, Koo YS, Park B, Jung KH, Kim M, Park KI, Jung KY, Chu K, Lee SK. Lim JA, et al. Ann Neurol. 2019 Mar;85(3):352-358. doi: 10.1002/ana.25421. Epub 2019 Feb 10. Ann Neurol. 2019. PMID: 30675918
OBJECTIVE: There is no scale for rating the severity of autoimmune encephalitis (AE). In this study, we aimed to develop a novel scale for rating severity in patients with diverse AE syndromes and to verify the reliability and validity of the …
OBJECTIVE: There is no scale for rating the severity of autoimmune encephalitis (AE). In this study, we aimed to dev
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.
Rogers JP, Oldham MA, Fricchione G, Northoff G, Ellen Wilson J, Mann SC, Francis A, Wieck A, Elizabeth Wachtel L, Lewis G, Grover S, Hirjak D, Ahuja N, Zandi MS, Young AH, Fone K, Andrews S, Kessler D, Saifee T, Gee S, Baldwin DS, David AS. Rogers JP, et al. J Psychopharmacol. 2023 Apr;37(4):327-369. doi: 10.1177/02698811231158232. Epub 2023 Apr 11. J Psychopharmacol. 2023. PMID: 37039129 Free PMC article.
Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, …
Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagn …
Validity and prognostic utility of clinical assessment scale for autoimmune encephalitis (CASE) score in children with autoimmune encephalitis.
Panda PK, Sharawat IK, Ramachandran A, Elwadhi A, Tomar A, Bhardwaj S, Murugan VK, Rajendiran R. Panda PK, et al. Brain Dev. 2023 Jan;45(1):8-15. doi: 10.1016/j.braindev.2022.09.009. Epub 2022 Oct 14. Brain Dev. 2023. PMID: 36253225
INTRODUCTION: The clinical assessment scale for autoimmune encephalitis (CASE) is a recently developed and validated scale to rate the severity of autoimmune encephalitis (AE) in adults. ...We also determined …
INTRODUCTION: The clinical assessment scale for autoimmune encephalitis (CASE) is a recently de
Validation of the Clinical Assessment Scale for Autoimmune Encephalitis: A Multicenter Study.
Cai MT, Lai QL, Zheng Y, Fang GL, Qiao S, Shen CH, Zhang YX, Ding MP. Cai MT, et al. Neurol Ther. 2021 Dec;10(2):985-1000. doi: 10.1007/s40120-021-00278-9. Epub 2021 Sep 2. Neurol Ther. 2021. PMID: 34476753 Free PMC article.
INTRODUCTION: A new scale, named the Clinical Assessment Scale for Autoimmune Encephalitis (CASE), has recently been developed for rating the severity of autoimmune encephalitis (AE) with a high level of clinim …
INTRODUCTION: A new scale, named the Clinical Assessment Scale for Autoimmune Encephalitis (CAS
Clinical Determinants of Longitudinal Disability in LGI-1-IgG Autoimmune Encephalitis.
Aboseif A, Li Y, Amin M, Lapin B, Milinovich A, Abbatemarco JR, Cohen JA, Punia V, Rae-Grant AD, Galioto R, Kunchok A. Aboseif A, et al. Neurol Neuroimmunol Neuroinflamm. 2023 Nov 10;11(1):e200178. doi: 10.1212/NXI.0000000000200178. Print 2024 Jan. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37949667 Free PMC article.
BACKGROUND AND OBJECTIVES: Longitudinal outcome studies in leucine-rich glioma inactivated-1 (LGI-1) immunoglobulin G (IgG) autoimmune encephalitis (AE) are needed to inform clinical management and prognostication. ...Disability and disease severity were defi …
BACKGROUND AND OBJECTIVES: Longitudinal outcome studies in leucine-rich glioma inactivated-1 (LGI-1) immunoglobulin G (IgG) autoimmune
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.
Zhang C, Zhang M, Qiu W, Ma H, Zhang X, Zhu Z, Yang CS, Jia D, Zhang TX, Yuan M, Feng Y, Yang L, Lu W, Yu C, Bennett JL, Shi FD; TANGO Study Investigators. Zhang C, et al. Lancet Neurol. 2020 May;19(5):391-401. doi: 10.1016/S1474-4422(20)30070-3. Lancet Neurol. 2020. PMID: 32333897 Free PMC article. Clinical Trial.
For the analyses of the primary outcome, the patients were prespecified into two subgroups according to concomitant autoimmune disease status. Safety was assessed in the full analysis set. ...In the prespecified subgroup analysis of the full analysis set stratified …
For the analyses of the primary outcome, the patients were prespecified into two subgroups according to concomitant autoimmune diseas …
The Patient Perspective in Encephalitis Research.
Finke C. Finke C. Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200189. doi: 10.1212/NXI.0000000000200189. Epub 2023 Dec 7. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38086067 Free PMC article.
Outcome measures in studies on autoimmune and infectious encephalitis mainly relied on established and widely used tools such as the modified Rankin Scale (mRS). ...Indeed, persisting cognitive deficits with their detrimental effect on quality of life …
Outcome measures in studies on autoimmune and infectious encephalitis mainly relied on established and widely used tool …
Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
Cleanthous S, Mork AC, Regnault A, Cano S, Kaminski HJ, Morel T. Cleanthous S, et al. Orphanet J Rare Dis. 2021 Oct 30;16(1):457. doi: 10.1186/s13023-021-02064-0. Orphanet J Rare Dis. 2021. PMID: 34717694 Free PMC article.
Our objective was to develop the MG Symptom patient-reported outcome (PRO) to assess key aspects of MG severity from the patient perspective. ...The MMP approach used may serve as a case study for developing PCOMs across rare disease indications....
Our objective was to develop the MG Symptom patient-reported outcome (PRO) to assess key aspects of MG severity from the patie …
Risk Prediction Models for Early ICU Admission in Patients With Autoimmune Encephalitis: Integrating Scale-Based Assessments of the Disease Severity.
Wu C, Fang Y, Zhou Y, Wu H, Huang S, Zhu S. Wu C, et al. Front Immunol. 2022 Jun 10;13:916111. doi: 10.3389/fimmu.2022.916111. eCollection 2022. Front Immunol. 2022. PMID: 35757708 Free PMC article.
BACKGROUND: In patients with autoimmune encephalitis (AE), the prediction of progression to a critically ill status is challenging but essential. However, there is currently no standard prediction model that comprehensively integrates the disease severity and other …
BACKGROUND: In patients with autoimmune encephalitis (AE), the prediction of progression to a critically ill status is challen …
Clinical outcomes of pediatric Anti-NMDA receptor encephalitis.
Shim Y, Kim SY, Kim H, Hwang H, Chae JH, Choi J, Kim KJ, Yum MS, Ko TS, Kim YO, Byeon JH, Lee J, Lee J, Kim JS, Lim BC. Shim Y, et al. Eur J Paediatr Neurol. 2020 Nov;29:87-91. doi: 10.1016/j.ejpn.2020.10.001. Epub 2020 Oct 6. Eur J Paediatr Neurol. 2020. PMID: 33046392
Clinical outcomes were evaluated using the Clinical Assessment Scale in Autoimmune Encephalitis (CASE) and the modified Rankin Scale (mRS). ...A specific outcome measure, such as CASE, should be adopted to delineate
Clinical outcomes were evaluated using the Clinical Assessment Scale in Autoimmune Encephalitis (
76 results